BurkhardtGESpencerJRGiffordSM. A large animal survival model (Sus scrofa) of extremity ischemia/reperfusion and neuromuscular outcomes assessment: a pilot study. J Trauma. 2010;69(suppl 1):S146-S153.
2.
AlamHBBurrisDDaCortaJARheeP. Hemorrhage control in the battlefield: role of new hemostatic agents. Mil Med. 2005;170:63-69.
3.
BlaisdellWF. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg. 2002;10:620-630.
4.
MurphyADMcCormackMCBicharaDA. Poloxamer 188 protects against ischemia-reperfusion injury in a murine hind-limb model. Plast Reconstr Surg. 2010;125:1651-1660.
5.
CrawfordRSAlbadawiHAtkinsMD. Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model. Surgery. 2010;148:110-118.